NCT05126589 Respiratory Virus Metagenomics After COVID-19
| NCT ID | NCT05126589 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | COVID-19 Respiratory Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2021-12-28 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2021-12-28 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to characterize the distributive pattern of viruses in upper airway and its relationship with influenza seasons, symptomatology and exposure setting. A total of 500 adults residing in Hong Kong would be recruited, who would complete a questionnaire and return self-collected nasal and throat swabs for metagenomic analyses.
Eligibility Criteria
Inclusion Criteria: * adults normally residing in Hong Kong * could communicate in English and/or Chinese * provision of consent Exclusion Criteria: * individuals with mental illness * prisoners
Contact & Investigator
Shui Shan Lee
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT05126589 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying COVID-19 Respiratory Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05126589 currently recruiting?
Yes, NCT05126589 is actively recruiting participants. Contact the research team at sslee@cuhk.edu.hk for enrollment information.
Where is the NCT05126589 trial being conducted?
This trial is being conducted at Hong Kong, China.
Who is sponsoring the NCT05126589 clinical trial?
NCT05126589 is sponsored by Chinese University of Hong Kong. The principal investigator is Shui Shan Lee at Chinese University of Hong Kong. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.